Invention Grant
- Patent Title: Cancer antigen-specific T-cell receptor gene, peptide encoded by the gene, and use of them
-
Application No.: US12529701Application Date: 2008-02-28
-
Publication No.: US10093977B2Publication Date: 2018-10-09
- Inventor: Haruo Sugiyama
- Applicant: Haruo Sugiyama
- Applicant Address: JP Osaka
- Assignee: International Institute of Cancer Immunology, Inc.
- Current Assignee: International Institute of Cancer Immunology, Inc.
- Current Assignee Address: JP Osaka
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, L.L.P.
- Priority: JP2007-054215 20070305
- International Application: PCT/JP2008/053469 WO 20080228
- International Announcement: WO2008/108257 WO 20080912
- Main IPC: C07H21/04
- IPC: C07H21/04 ; C12Q1/6881 ; C07K14/725 ; C12Q1/6886 ; G01N33/569 ; G01N33/574
Abstract:
Disclosed are: a nucleotide sequence and an amino acid sequence for CDR3 region of T-cell receptor (TCR) gene of WT1-specific cytotoxic T-cell (CTL) for WT1 protein; a method for the detection or treatment of cancer using the nucleotide sequence or the amino acid sequence; and a chip, a primer set, a kit, an apparatus and the like for use in the detection of cancer, each of which comprises the nucleotide sequence or the amino acid sequence.
Public/Granted literature
- US09315865B2 Cancer antigen-specific T-cell receptor gene, peptide encoded by the gene, and use of them Public/Granted day:2016-04-19
Information query
